Related Experiment Video
Updated: Jan 26, 2026

Whole-body PET/MRI of Pediatric Patients: The Details That Matter
Published on: December 19, 2017
A Pediatric Case of Transformed Mycosis Fungoides in a BRCA2 Positive Patient
Andrea M Gross1,2, Joyce Turner1, Anna Y Kirkorian1
1Children's National Medical Center, Washington, DC.
Abstract:
Cutaneous T-cell lymphomas are very rare in children. Although mycosis fungoides is the most common of these rare cutaneous T-cell lymphomas in children, transformation to an aggressive malignancy remains extremely uncommon, and there are no clear guidelines for clinical management in the pediatric population. In addition, the increased usage of next-generation sequencing for pediatric patients with unusual malignancies may result in the discovery of pathogenic germline mutations, though the association between these mutations and the patient's cancer is not always clear. We present here a unique pediatric case of transformed mycosis fungoides in a patient with BRCA2 mutation.
Insights
This study details a rare pediatric case of transformed mycosis fungoides in a child with a BRCA2 mutation. It highlights the uncommon nature of this aggressive malignancy and the potential link to germline mutations.
Area of Science:
- Pediatric Oncology
- Dermatology
- Cancer Genetics
Background:
- Cutaneous T-cell lymphomas (CTCLs) are exceptionally rare in children.
- Mycosis fungoides is the most common CTCL in pediatric patients, but transformation to advanced stages is very uncommon.
- Clinical management guidelines for pediatric CTCLs are lacking.
Observation:
- Next-generation sequencing is increasingly used in pediatric oncology, potentially identifying germline mutations.
- The clinical significance of discovered germline mutations in pediatric cancers is not always clear.
- A unique case of transformed mycosis fungoides in a pediatric patient with a known BRCA2 mutation is presented.
Findings:
- The case highlights a rare instance of aggressive CTCL progression in a child.
- The presence of a BRCA2 mutation in this pediatric patient suggests a potential, though not fully elucidated, association with the disease.
- This case underscores the complexity of diagnosing and managing rare pediatric malignancies.
Implications:
- This case may inform future research into the genetic underpinnings of pediatric CTCLs.
- Further investigation is needed to understand the role of germline mutations like BRCA2 in pediatric mycosis fungoides.
- This report contributes to the limited literature on managing transformed mycosis fungoides in children.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Bacterial Transformation
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Position-effect Variegation

